A Narrative Review of Statin-Induced Rhabdomyolysis: Molecular Mechanism, Risk Factors, and Management
Nisa Safitri,1 Maya Fadila Alaina,1 Dian Ayu Eka Pitaloka,1,2 Rizky Abdulah1,2 1Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, Indonesia; 2Center of Excellence in Higher Education for Pharmaceutical Care Innovation, Universitas Padjad...
Guardado en:
Autores principales: | Safitri N, Alaina MF, Pitaloka DAE, Abdulah R |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/350af02f4aaa40fcb81aa10bc55ef00b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Trametinib and dabrafenib induced rhabdomyolysis, renal failure, and visual loss. Report of one case
por: Finsterer,Josef
Publicado: (2020) -
Frequency of Common Variants in Genes Involved in Lipid-Lowering Response to Statins in Chilean Subjects with Hypercholesterolemia
por: Rosales,Alexy, et al.
Publicado: (2011) -
A Case Report of Severe Rhabdomyolysis after Lovastatin and Diltiazem Consumption
por: M Baradaran, et al.
Publicado: (2010) -
El perfil de seguridad de las estatinas
por: Prieto D,Juan Carlos
Publicado: (2001) -
Laxative-induced rhabdomyolysis
por: Alfonso Merante, et al.
Publicado: (2010)